Sort
141,003 grants matching “cytokine”
Clinical Risk Factors for Primary Graft Dysfunction
$915,565Jason D Christie · University Of Pennsylvania · R01 · FY2014 · HL
Role of proviral loci in HIV latency
$915,358James Ivan Mullins · University Of Washington · R01 · FY2016 · AI
Therapy and Prophylaxis for Genital Tract Infection
$915,331Dominick Auci · Therapyx, Inc. · R44 · FY2022 · AI
Transfusion-Related Acute Lung Injury: Incidence and Mechanisms
$915,052Pearl T Toy · University Of California, San Francisco · P50 · FY2008 · HL
Modulating Indoleamines to Optimize Immunity in the Setting of Mtb/HIV Co-infection
$914,927Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2024 · AI
OPTIMIZED SYNTHETIC TLR LIGANDS FOR BIODEFENSE
$914,900University Of California San Diego · U01 · FY2004 · AI
Precision Medicine in Sarcoidosis
$914,660Patricia W Finn · University Of Illinois At Chicago · R01 · FY2020 · HL
A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
$914,660Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · DK
Precision Medicine in Sarcoidosis
$914,660Patricia W Finn · University Of Illinois At Chicago · R01 · FY2019 · HL
COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE
$914,646American College Of Radiology · U10 · FY2003 · CA
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$914,594Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2009 · AI
Importance of Endothelial Cell-Cell Communication at the Maternal Fetal Interface
$914,457Ian M Bird · University Of Wisconsin-Madison · P01 · FY2015 · HD
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$914,341Kory J. Lavine · Washington University · R35 · FY2024 · HL
First Comprehensive Mitochondrial DNA Brain Mutation Atlas for Alzheimer's Disease
$914,157Bradley J Willcox · Kuakini Medical Center · R01 · FY2025 · AG
A Novel Th17-inducing Mucosal Vaccine for Tuberculosis
$914,044Shabaana A. Khader · University Of Chicago · R01 · FY2023 · AI
Commercialization of Human Mesothelial Cells for Research
$913,158Yolanda Renee Lea-Currie · Zen-Bio, Inc. · R44 · FY2009 · RR
Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis
$913,097Scott Scarneo · Eydis Bio, Inc. · R44 · FY2022 · AR
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients
$913,096Olivia M Martinez · Stanford University · U01 · FY2019 · AI
Precision Medicine in Sarcoidosis
$912,947Jeffrey R Jacobson · University Of Illinois At Chicago · R01 · FY2021 · HL
Discrimination of nonself by innate immune receptors
$912,922Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Immunoregulatory Defects In Inflammatory Bowel Disease
$912,859Warren Strober · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Regulation of T cell Differentiation
$912,859Warren Strober · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Nuclear Factor-kappaB in Ovarian Cancer
$912,704Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Brain Cell Death Mechanisms after Perinatal Ischemia
$912,535Jose Regino Perez-Polo · University Of Texas Med Br Galveston · P01 · FY2006 · HD
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2020 · CA